MedPath

SALT studie – Stadiëring met [18F]PSMA PET voorafgaand aan lymfeklierdissectie bij patiënten met een prostaattumor

Recruiting
Conditions
primary prostate cancer
Registration Number
NL-OMON26080
Lead Sponsor
VU University Medical Center, Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Histologically confirmed prostate cancer;

planned voor radicale prostatectomy in combination with an ePLND;

Exclusion Criteria

multiple malignancies;

claustrophobia

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of [18F]DCFPyL PET/CT for pelvic lymph nodes (sensitivity, specificity, PPV, NPV)
Secondary Outcome Measures
NameTimeMethod
Diagnostic accuracy of [18F]DCFPyL PET/CT for distant metastases (PPV)
© Copyright 2025. All Rights Reserved by MedPath